Distinct structural requirements for CDON and BOC in the promotion of Hedgehog signaling  by Song, Jane Y. et al.
Developmental Biology 402 (2015) 239–252Contents lists available at ScienceDirectDevelopmental Biologyhttp://d
0012-16
n Corr
E-mjournal homepage: www.elsevier.com/locate/developmentalbiologyDistinct structural requirements for CDON and BOC in the promotion
of Hedgehog signaling
Jane Y. Song a, Alexander M. Holtz a,b,c, Justine M. Pinskey a, Benjamin L. Allen a,n
a Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI 48109, USA
b Medical Scientist Training Program, University of Michigan, Ann Arbor, MI 48109, USA
c Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, MI 48109, USAa r t i c l e i n f o
Article history:
Received 29 August 2014
Received in revised form
3 March 2015
Accepted 25 March 2015







06/& 2015 Elsevier Inc. All rights reserved.
esponding author. Fax: þ1 7347631166.
ail address: benallen@umich.edu (B.L. Allen).Proper levels of Hedgehog (HH) signaling are essential during embryonic development and adult tissue
homeostasis. A central mechanism to control HH pathway activity is through the regulation of secreted
HH ligands at the plasma membrane. Recent studies have revealed a collective requirement for the cell
surface co-receptors GAS1, CDON and BOC in HH signal transduction. Despite their requirement in HH
pathway function, the mechanisms by which these proteins act to promote HH signaling remain poorly
understood. Here we focus on the function of the two structurally related co-receptors, CDON and BOC.
We utilized an in vivo gain-of-function approach in the developing chicken spinal cord to dissect the
structural requirements for CDON and BOC function in HH signal transduction. Notably, we ﬁnd that
although CDON and BOC display functional redundancy during HH-dependent ventral neural patterning,
these molecules utilize distinct molecular mechanisms to execute their HH-promoting effects. Speciﬁ-
cally, we deﬁne distinct membrane attachment requirements for CDON and BOC function in HH signal
transduction. Further, we identify novel and separate extracellular motifs in CDON and BOC that are
required to promote HH signaling. Together, these data suggest that HH co-receptors employ distinct
mechanisms to mediate HH pathway activity.
& 2015 Elsevier Inc. All rights reserved.Introduction
Hedgehog (HH) signaling is required throughout embryonic
development for the proper patterning and growth of a multitude of
tissues and organs (McMahon et al., 2003). The actions of secreted
HH ligands are tightly regulated at the cell surface through complex
interactions with myriad cell surface-associated and extracellular
matrix proteins (reviewed in Briscoe and Therond (2013). Core cell
surface components of the HH signaling pathway include the
canonical twelve-pass transmembrane receptor Patched (PTCH1)
that antagonizes the function of the GPCR-like protein Smoothened
(SMO), which mediates downstream signal transduction upon HH
pathway activation (Chen and Struhl, 1996; Marigo et al., 1996; Stone
et al., 1996; van den Heuvel and Ingham, 1996). In addition to these
core components that are conserved across species, we have
recently deﬁned an essential role for two vertebrate-speciﬁc cell
surface antagonists of the pathway, HH-interacting protein 1
(HHIP1) and PTCH2, that act redundantly with PTCH1 to limit HH
pathway function (Holtz et al., 2013). These molecules oppose the
activity of three HH pathway co-receptors: CAM-related/down-
regulated by oncogenes (CDON), brother of CDON (BOC), and growtharrest-speciﬁc 1 (GAS1) that together are essential to transduce HH
signaling during embryonic development (Allen et al., 2011). Despite
their requirement in vertebrate HH signal transduction, the
mechanisms by which these cell surface components control HH
signaling remain largely unexplored.
CDON and BOC are conserved from Drosophila (ihog and boi
respectively) to mammals (Kang et al., 2002; Lum et al., 2003). These
proteins consist of a series of extracellular immunoglobulin (IG) and
ﬁbronectin type III (FN) domains, a single-pass transmembrane (TM)
domain, and a large, divergent cytoplasmic (CD) domain (Kang et al.,
1997; Kang et al., 2002). Recent studies in Drosophila have identiﬁed
essential roles for Ihog and Boi in HH signal transduction in the wing
imaginal disc (Camp et al., 2010; Zheng et al., 2010). However, in
mammals, these co-receptors function redundantly with a third,
vertebrate-speciﬁc cell surface protein, GAS1, to mediate HH-
dependent ventral neural patterning (Allen et al., 2011). These co-
receptors function not only during spinal cord development, but also
in other HH-dependent processes, including cerebellar development,
digit speciﬁcation, and craniofacial development (Allen et al., 2011,
2007; Cole and Krauss, 2003; Izzi et al., 2011; Zhang et al., 2011).
CDON mutations have been identiﬁed in human holoprosencephaly
(Bae et al., 2011), while craniofacial defects in Cdon mutant mice can
be modiﬁed by environmental factors (Hong and Krauss, 2013) as
well as Boc deletion (Zhang et al., 2011). In contrast to the redun-
dancy observed during craniofacial development, BOC, but not
Fig. 1. General membrane tethering is sufﬁcient for CDON-mediated HH signaling. (A–X) Antibody detection of NKX2.2 (red) in forelimb level transverse sections of
Hamburger–Hamilton stage 21–22 chicken neural tubes electroporated with Cdon (A–D), CdonΔCD (E–H), CdonΔTMCD (I–L), CdonΔCLS (M–P), Cdon::CD4 (Q–T), and Cdon::GPI
(U–X). GFPþ cells (green) designate electroporated cells and DAPI (grayscale) marks nuclei. Merged images are shown on the right, including quantitation of the number of
embryos that display ectopic NKX2.2 expression (denoted by arrows). Scale bar, 10 μm. (Y) Western blot analysis of COS-7 cell lysates following transfection with the
speciﬁed constructs and probed with anti-CDON antibody and anti-Beta-tubulin as a loading control. ImageJ quantitation of relative expression levels is expressed as a
histogram below the western blots. (Z) Western blot analysis of cell supernatants collected from COS-7 cells transfected with Cdon, CdonΔTMCD, Cdon::CD4, and Cdon::GPI.
Cells were untreated (left lanes) or PI-PLC treated (right lanes) prior to supernatant collection. (A’) Schematic illustrating membrane-proximal amino acids that were deleted
to generate the CdonΔCLS construct.
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2010; Okada et al., 2006).
Currently, the prevailing paradigm is that CDON and BOC pro-
mote HH signaling through calcium-dependent interactions with HH
ligands via a membrane-proximal FN domain, FNIII(3) (McLellan
et al., 2008), and interactions with the canonical receptor PTCH1
mediated by two distal FN repeats (Bae et al., 2011; Izzi et al., 2011).
However, to date, a comprehensive assessment of the structural
determinants in CDON and BOC that are required to mediate HH
pathway function have not been explored.
Here we dissect the domains of CDON and BOC that are required
to promote HH signaling through detailed structure-function ana-
lyses in the developing spinal cord. We deﬁne multiple motifs in
these proteins that are required to promote HH signaling. Surpris-
ingly, we ﬁnd that CDON and BOC require different modes of
membrane attachment and utilize distinct extracellular domains to
mediate HH pathway activity. Together, these data indicate that
CDON and BOC employ separate mechanisms to promote HH path-
way function.Results
Distinct membrane attachment requirements for CDON- and BOC-
mediated promotion of HH-dependent neural patterning
To dissect the structural requirements of CDON and BOC in HH
pathway function, we utilized a gain-of-function approach in the
developing chicken spinal cord, one of the best-studied sites of HH
signaling. In agreement with previous studies (Allen et al., 2011;
Tenzen et al., 2006), electroporation of a full-length Cdon construct
promotes cell autonomous ectopic expression of the HH-depen-
dent interneuron progenitor (pV3) marker NKX2.2 (Fig. 1A–D).
Similarly, electroporation of a truncated Cdon construct lacking the
cytoplasmic domain (CdonΔCD) also promotes ectopic NKX2.2
expression (Fig. 1E–H). In contrast, electroporation of a secreted
form of CDON (CdonΔTMCD) does not alter HH-dependent neural
patterning (Fig. 1I–L). Together with previous work (Tenzen et al.,
2006), these data suggest that membrane anchoring of CDON is
required to mediate HH signal transduction.
Previous studies have described the ciliary localization of mem-
brane-associated HH pathway components, including SMO, PTCH1
and PTCH2 (Corbit et al., 2005; Holtz et al., 2013; Rohatgi et al., 2007;
Santos and Reiter, 2014). While we do not detect localization of
CDON in primary cilia (data not shown), CDON does possess a
potential cilia localization sequence at the carboxy-terminus of the
transmembrane domain (Fig. 1A’) (Corbit et al., 2005). Notably
deletion of this sequence in CDON (CdonΔCLS) does not compromise
the promotion of HH-dependent neural patterning (Fig. 1M–P).
Given the requirement for CDON membrane attachment in the
promotion of HH signaling, we next sought to assess whether the
mode of membrane attachment affects CDON function. Replace-
ment of the transmembrane domain of CDON with the well-
characterized transmembrane domain of the cell surface protein
CD4 (Cdon::CD4) (Maddon et al., 1985) does not alter ectopic HH-
dependent NKX2.2 speciﬁcation (Fig. 1Q–T). Remarkably, expres-
sion of a GPI-anchored CDON protein (Cdon::GPI) also promotes
ectopic HH pathway activation (Fig. 1U–X). Signiﬁcantly, we
observed identical results with immunodetection of other HH
pathway targets, including the motor neuron progenitor (pMN)
marker OLIG2 (Fig. S1) as well as the class-II transcription factor
NKX6.1 (Fig. S2).
We utilized PI-PLC treatment (Low, 1987) to conﬁrm that
CDON::GPI is anchored to the cell surface through phosphatidyli-
nositol (Fig. 1Z). Secreted CDON (CdonΔTMCD) is constitutively
detected in cell supernatants, while CDON::GPI accumulates onlyin PI-PLC-treated supernatants. In contrast, PI-PLC treatment does
not promote the accumulation of either full-length CDON or
CDON::CD4 (Fig. 1Z).
We also employed SDS-PAGE and western blot analysis to
determine the relative expression of each Cdon construct (Fig. 1Y).
Further, we engineered a Hemagglutinin (HA) epitope tag into each
construct to permit protein detection in situ in the chicken neural
tube (Fig. S3A–L). Collectively, these data suggest that while CDON
requires membrane attachment to promote HH signaling, there are
no speciﬁc requirements in the type of membrane association nee-
ded to mediate CDON-dependent HH pathway activation.
To assess whether membrane anchoring is generally required for
other HH co-receptors, we performed an analogous set of experi-
ments for BOC (Fig. 2). Similar to CDON, full-length BOC promotes
cell-autonomous ectopic neural progenitor speciﬁcation (Fig. 2A–D).
Additionally, the cytoplasmic domain of BOC (BocΔCD) is dispensable
for the promotion of HH signaling (Fig. 2E–H), while a secreted
version of BOC (BocΔTMCD) is unable to mediate ectopic HH-
dependent progenitor speciﬁcation (Fig. 2I–L). Further, deletion of a
putative cilia localization sequence at the carboxy-terminus of the
BOC transmembrane domain (BocΔCLS) does not perturb BOC
function (Fig. 2M–P, A’). These data suggest that BOC and CDON both
require membrane tethering to promote HH pathway function.
To further assess the requirement for BOC membrane tethering,
we generated Boc::CD4 and Boc::GPI constructs. Electroporation of
Boc::CD4 promotes ectopic NKX2.2þ cell speciﬁcation in the ventral
neural tube (Fig. 2Q–T). However, Boc::GPI does not induce HH
pathway activation (Fig. 2U–X). This failure to promote signaling was
not due to reduced protein expression, as western blot analysis
indicated relatively equal expression of full-length BOC and BOC::GPI
(Fig. 2Y). Further, we used antibody detection of epitope (HA)-tagged
BOC in the chicken neural tube to conﬁrm BOC::GPI expression (Fig.
S4A–L). However, western blot analysis revealed that secreted BOC
protein is detected in supernatants collected from cells expressing
full-length BOC, as well as BOC::CD4 and BOC::GPI, even in the
absence of PI-PLC treatment (Fig. 2Z). These data contrast with CDON
(cf. Fig. 1Z), and suggest that BOC undergoes proteolytic cleavage,
resulting in its release from the cell surface. Notably, sequence ana-
lysis of BOC and CDON identiﬁed a putative matrix metallopeptidase
9 recognition site present in a juxtamembrane region of BOC, but not
CDON (Song et al., 2012). To test whether this represents a functional
cleavage site, we generated a Boc construct in which the juxta-
membrane sequence containing the putative protease cleavage site
was deleted (BocΔFN-TM linker). We also included an N-terminal HA
epitope tag and a C-terminal MYC tag to validate this result. Strik-
ingly, we detected two populations of secreted BOC (100 kDa and
37 kDa) in supernatants from cells expressing full-length BOC
(HA::Boc::MYC; Fig. 3A). In contrast, deletion of the juxtamembrane
region (HA::BocΔFN-TM linker::MYC) abrogates the detection of the
100 kDa band in cell supernatants (Fig. 3A). Similarly, we detected
a truncated (37 kDa) C-terminal BOC fragment inwhole cell lysates
from cells expressing full-length BOC (Fig. 3B), that is absent in
lysates from cells expressing a version of BOC lacking the putative
cleavage site (Fig. 3B). These data suggest an extracellular cleavage
event that results in release of a large BOC fragment from the cell
surface and the generation of a truncated, membrane tethered
cytoplasmic fragment. Importantly, electroporation of this construct
(HA::BocΔFN-TM linker::MYC) completely abrogates BOC-mediated
promotion of HH signaling in the developing chicken neural tube,
including the speciﬁcation of targets that require low levels of HH
signaling (Fig. 3C–N). These data indicate that, similar to CDON,
membrane tethering of BOC is a key determinant of its function.
However, unlike CDON, BOC contains a putative extracellular clea-
vage site that may regulate its activity during HH-dependent neural
patterning.
Fig. 2. BOC requires integral membrane anchoring to mediate HH signal transduction. (A–X) Forelimb level transverse sections of Hamburger–Hamilton stage 21–22 chicken
neural tubes electroporated with Boc (A–D), BocΔCD (E–H), BocΔTMCD (I–L), BocΔCLS (M–P), Boc::CD4 (Q–T), and Boc::GPI (U–X) stained with anti-NKX2.2 antibody (red).
GFPþ cells (green) denote electroporated cells and nuclei are stained with DAPI (grayscale). Merged images are shown at the right, including quantitation of the number of
embryos that display ectopic NKX2.2 expression (denoted by arrows). Scale bar, 10 μm. (Y) Western Blot Analysis of COS-7 cell lysates following transfection with the
speciﬁed constructs and probed with anti-BOC antibody and anti-Beta-tubulin as a loading control. ImageJ quantitation of relative expression levels are expressed as a
histogram below the western blots. (Z) Western blot analysis of cell supernatants collected from COS-7 cells transfected with Boc, BocΔTMCD, Boc::CD4, and Boc::GPI. (A’)
Schematic illustrating membrane-proximal amino acids that were deleted to generate the BocΔCLS construct.
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Fig. 3. BOC undergoes extracellular proteolytic cleavage mediated by a juxtamembrane domain. (A) Western blot analysis of supernatants from COS-7 cells transfected with
pCIG, HA::Boc::MYC, or HA::BocΔFN-TM linker::MYC, probed with anti-HA antibody. Note the presence of a 100 kDa band in the HA::BOC::MYC lane, but not the
HA::BOCΔFN-TM linker::MYC lane, while a 37 kDa band is detected in both lanes. (B) Western blot analysis of whole cell lysates probed with anti-MYC antibody and anti-Beta-
tubulin as a loading control. (C–N) Forelimb level transverse sections of Hamburger–Hamilton stage 21–22 chicken neural tubes electroporated with BocΔFN-TM linker, and
stained with DAPI (grayscale; C,G,K), and antibodies against NKX2.2 (red; E,F), OLIG2 (red; I,J), or NKX6.1 (red; M,N). GFPþ cells denote electroporated cells (green; D,H,L).
Merged images are shown at the right, including quantitation of the number of embryos that display ectopic NKX2.2, OLIG2 or NKX6.1 expression. Scale bar (C), 10 μm.
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HH signaling
The different membrane attachment requirements for CDON and
BOC function suggest that these proteins do not convey HH signals
identically. Instead these data suggest a model where distinct ele-
ments in the extracellular domains of CDON and BOC contribute to
the promotion of HH pathway activity. To test this notion, we again
utilized gain-of-function experiments in the chicken neural tube
(Fig. 4). The extracellular domain of CDON consists of ﬁve amino-
terminal IG domains and three membrane-proximal FNIII repeats(Kang et al., 1997). In support of previous studies (Tenzen et al.,
2006), and in contrast to full-length CDON (Fig. 4A–D), deletion of
the HH ligand-binding FNIII(3) domain of CDON [CdonΔFNIII(3)]
abrogates ectopic HH-dependent neural progenitor speciﬁcation
(Fig. 4I–L). Further, the FNIII(3) domain of CDON is not sufﬁcient to
promote HH pathway activation in the chicken neural tube (Fig. 4E–
H). These data suggest that additional extracellular domains are
required to mediate CDON function. Recent studies indicate that the
FNIII(1) and FNIII(2) domains of CDON and BOC mediate interac-
tions with the canonical HH receptor PTCH1, as well as with all
three co-receptors (GAS1, CDON and BOC) (Bae et al., 2011; Izzi
Fig. 4. The FNIII domains of CDON are sufﬁcient to promote HH signaling. (A–X) Forelimb level transverse sections of Hamburger–Hamilton stage 21–22 chicken neural tubes
electroporated with Cdon (A–D), CdonFNIII(3) (E–H), CdonΔFNIII(3) (I–L), CdonFNIII(1–3) (M–P), CdonFNIII(2,3) (Q–T), and CdonFNIII(1,3) (U–X) stained with anti-NKX2.2
antibody (red). GFP expression (green) indicates electroporated cells and DAPI (grayscale) identiﬁes nuclei. Merged images are shown on the right, including quantitation of
the number of embryos that display ectopic NKX2.2 expression (denoted by arrows). Scale bar, 10 μm. (Y) Western blot analysis of COS-7 cell lysates following transfection
with the speciﬁed constructs and probed with anti-CDON antibody and anti-Beta-tubulin as a loading control (left panel). ImageJ quantitation of relative expression levels is
expressed as a histogram (right panel).
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cient to stimulate HH signaling, we generated a construct lacking all
ﬁve IG domains [CdonFNIII(1–3)]. Our data indicate that CdonFNIII(1–3) is indeed sufﬁcient to promote HH-dependent neural pattern-
ing (Fig. 4M–P). To examine potential functional redundancy bet-
ween the FNIII(1) and FNIII(2) repeats, we generated two additional
Fig. 5. The FNIII domains of BOC are not sufﬁcient to promote HH signaling. (A–X) Forelimb level transverse sections of Hamburger–Hamilton stage 21–22 chicken neural
tubes electroporated with Boc (A–D), BocFNIII(3) (E–H), BocΔFNIII(3) (I–L), BocFNIII(1-3) (M–P), BocΔFNIII(1) (Q–T), and BocΔFNIII(2) (U–X) stained with anti-NKX2.2 antibody
(red). Green (GFPþ) cells denote electroporated cells and nuclei are identiﬁed by DAPI (grayscale). Merged images are shown on the right, including quantitation of the
number of embryos that display ectopic NKX2.2 expression (denoted by arrows). Scale bar, 10 μm. (Y) Western Blot Analysis of COS-7 cell lysates following transfection with
the speciﬁed constructs and probed with anti-HA and anti-MYC antibodies and anti-Beta-tubulin as a loading control (left panel). ImageJ quantitation of relative expression
levels is expressed as a histogram (right panel).
J.Y. Song et al. / Developmental Biology 402 (2015) 239–252 245constructs: CdonFNIII(2,3) and CdonFNIII(1,3). Following electropora-
tion in the chicken neural tube, both constructs promotes ectopic
NKX2.2þ cell speciﬁcation (Fig. 4Q–X), suggesting that, together with
the ligand-binding FNIII(3) domain, either the FNIII(1) or the FNIII
(2) domain of CDON is sufﬁcient to promote HH signaling.Differential extracellular requirements for BOC-mediated promotion
of HH signaling
We employed the same approach to evaluate the extracellular
requirements for BOC-mediated promotion of HH signaling. Again,
J.Y. Song et al. / Developmental Biology 402 (2015) 239–252246full-length BOC induces cell autonomous expression of ectopic
NKX2.2 (Fig. 5A–D); similar to CDON, the HH ligand-binding
domain of BOC, FNIII(3), is necessary, but not sufﬁcient to promote
HH signaling (Fig. 5E–L). Strikingly, and in contrast to CDON,
expression of a construct containing all three BOC FNIII domains,
BocFNIII(1–3), does not activate HH signaling (Fig. 5M–P). Impor-
tantly, BOCFNIII(1–3) protein is expressed equivalently to full-
length BOC protein in vitro as assessed by western blot analysis
(Fig. 5Y), while immunoﬂuorescent staining conﬁrms expression
of BOCFNIII(1–3) in the chicken neural tube (Fig. S4Q–R). TheseFig. 6. Chimeric constructs reveal functional differences between the FNIII domains of
stage 21–22 chicken neural tubes electroporated with BocFNIII(1–3) (A–D), CdonFNIII(1–3
with anti-NKX2.2 antibody (red). Green (GFPþ) cells depict electroporated cells and n
including quantitation of the number of embryos that display ectopic NKX2.2 expression
following transfection with the speciﬁed constructs and probed with anti-HA antibody a
expression levels is expressed as a histogram (right panel).data suggest that BOC requires additional extracellular determi-
nants to promote HH signaling. Notably, individual deletion of
either the FNIII(1) or FNIII(2) domains of BOC does not alter BOC
function (Fig. 5Q–X), suggesting that unlike the FNIII(3) domain,
these domains are not required to promote HH signal transduc-
tion. We also generated a construct deleting both FNIII(1) and FNIII
(2); however, this construct, BocΔFNIII(1,2), is not efﬁciently
expressed in the chicken neural tube (data not shown), precluding
further analysis of the combined requirement for these domains.
Taken together, these results support the view that, compared toCDON and BOC. (A–P) Forelimb level transverse sections of Hamburger–Hamilton
) (E–H), BocFNIII(1,2)/CdonFNIII(3) (I–L), and CdonFNIII(1,2)/BocFNIII(3) (M–P) stained
uclei are identiﬁed by DAPI (grayscale). Merged images are shown on the right,
(denoted by arrows). Scale bar, 10 μm. (Q) Western Blot Analysis of COS-7 cell lysates
nd anti-Beta-tubulin as a loading control (left panel). ImageJ quantitation of relative
J.Y. Song et al. / Developmental Biology 402 (2015) 239–252 247CDON, BOC requires additional extracellular determinants to suc-
cessfully activate the HH pathway.
Chimeric constructs reveal functional differences between the FNIII
domains of CDON and BOC
To further dissect the discrepancy in CDON and BOC function,
we generated chimera constructs by interchanging the ﬁrst two
FNIII repeats of CDON and BOC. The ﬁrst construct, BocFNIII(1,2)/
CdonFNIII(3), was produced by inserting FNIII(1) and FNIII(2) of
BOC into the CdonFNIII(3) construct. That is, the signal peptide,Fig. 7. CDON and BOC association with PTCH1 does not correlate with the promotion of
co-expressing PTCH1::MYC. Immunoprecipitates (IP) and whole cell lysates (WCL) wer
against MYC (α-MYC) and HA (α-HA). (B) Immunoprecipitation of HA-tagged CDON and B
MYC co-precipitates with both CDONFNIII(1–3) and BOCFNIII(1–3).FNIII(3) domain, transmembrane domain, and cytoplasmic domain
were all from CDON, while the ﬁrst two FNIII repeats were from
BOC. We also generated a similar chimeric construct, CdonFNIII
(1,2)/BocFNIII(3), in which the ﬁrst two FN domains of BOC were
replaced with those from CDON (Fig. 6).
Unlike the CdonFNIII(1–3) construct that promotes HH signal-
ing (Fig. 6E–H), expression of the BocFNIII(1,2)/CdonFNIII(3) chi-
meric construct in the chicken neural tube fails to promote HH
signaling (Fig. 6I–L). Conversely, the reciprocal chimeric construct,
CdonFNIII(1,2)/BocFNIII(3), does promote ectopic HH pathway
activity (Fig. 6M–P), in direct opposition to the BocFNIII(1–3)HH signaling. (A) Immunoprecipitation of CDON::HA and BOC::HA from COS-7 cells
e subjected to SDS-PAGE and western blot analysis (IB) using antibodies directed
OC FNIII constructs from COS-7 cells co-expressing PTCH1::MYC. Note that PTCH1::
Fig. 8. Identiﬁcation of a novel motif in BOC required to promote HH signal transduction. (A–X) Forelimb level transverse sections of Hamburger–Hamilton stage 21–22
chicken neural tubes electroporated with BocFNIII(1–3) (A–D), BocFNIII(1-3)IG-FN linker (E–H), BocFNIII(1,3)IG-FN linker (I–L), BocFNIII(2,3)IG-FN linker (M–P), BocFNIII(3)IG-FN linker
(Q–T), and BocΔIG-FN linker (U–X) stained with anti-NKX2.2 antibody (red). GFPþ cells denote electroporated cells (green) and DAPI (grayscale) marks nuclei. Merged
images are shown on the right, including quantitation of the number of embryos that display ectopic NKX2.2 expression (denoted by arrows). Scale bar, 10 μm. (Y) Western
Blot Analysis of COS-7 cell lysates following transfection with the speciﬁed constructs and probed with anti-HA antibody and anti-Beta-tubulin as a loading control (left
panel). ImageJ quantitation of relative expression levels is expressed as a histogram (right panel).
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these constructs are expressed at similar levels in vitro as assessed
by western blot analysis (Fig. 6Q), and expression of the chimeric
constructs in the chicken neural tube was conﬁrmed by immu-
noﬂuorescent staining (Fig S5M–P). These data suggest that the
FNIII(1) and FNIII(2) domains of CDON can promote HH signal
transduction while the homologous domains of BOC cannot, even
in the heterologous context of CDON.
To explore whether this difference in CDON and BOC function is
due to differences in association with the canonical receptor PTCH1,
we performed immunoprecipitation experiments with the various
CDON and BOC FNIII chimeras (Fig. 7). We initially conﬁrmed that
PTCH1 co-precipitates with CDON and BOC (Fig. 7A), similar to pre-
vious studies (Bae et al., 2011; Izzi et al., 2011). Surprisingly, we found
that PTCH1 co-precipitates with both CDONFNIII(1–3) and BOCFNIII(1–3)
(Fig. 7B), even though BOCFNIII(1–3) does not promote HH signaling (cf.
Fig. 6A–H). Counterintuitively, we also observed that PTCH1 co-pre-
cipitates with BOCFNIII(1,2)/CDONFNIII(3) (which does not promote HH
signaling), but does not co-precipitate with CDONFNIII(1,2)/BOCFNIII(3)
(which does promote HH signaling; Fig. 7B). Together these data
suggest that (1) differential association with PTCH1 does not explain
the difference in CDON and BOC function, and that (2) association
with PTCH1 is not required for the promotion of HH-dependent
neural patterning.Identiﬁcation of a novel motif in BOC required to promote HH signal
transduction
The discovery that the FNIII domains of BOC are not sufﬁcient
to promote HH pathway activity suggests an additional extra-
cellular requirement for BOC function. Through a series of addi-
tional structure-function experiments (data not shown), we
identiﬁed a 78-amino acid region in BOC bridging the conserved
IG and FNIII domains (IG-FN linker) as a candidate regulator of HH
activity. To test whether this IG-FN linker is required for BOC-
mediated promotion of HH signaling, we generated a construct
containing the linker region along with all three FNIII domains of
BOC, referred to as BocFNIII(1-3)IG-FN linker (Fig. 8).
Signiﬁcantly, we ﬁnd that BocFNIII(1–3)IG-FN linker induces HH
pathway activity equivalently to full-length BOC, and in contrast to
BocFNIII(1–3) lacking this region (Fig. 8A–H). Further, we performed
analogous experiments to CDON, generating constructs lacking either
the FNIII(1) or FNIII(2) repeats, but with an intact linker region. Both
constructs, BocFNIII(1,3)IG-FN linker, and BocFNIII(2,3)IG-FN linker, promote
HH signaling (Fig. 8I–P), similar to previous constructs lacking only
the FNIII(1) or FNIII(2) domains (cf. Fig. 5Q–X). To assess whether the
linker region is sufﬁcient to foster HH-dependent neural patterning,
we generated a membrane-anchored construct containing the linker
region and the ligand-binding FNIII(3) domain, BocFNIII(3)IG-FN linker.
Expression of this construct in the chicken neural tube does not
rescue SHH signal transduction (Fig. 8Q–T). Conversely, to determine
the necessity of the linker region, we deleted this region from full-
length BOC (BocΔIG-FN linker). This construct still promotes ectopic
NKX2.2þ progenitor cell speciﬁcation (Fig. 8U–X), suggesting that
the linker region is not necessary to promote HH signaling in the
context of full-length BOC protein. We conﬁrmed the expression of
these constructs via immunostaining and western blot analysis (Fig.
S5A–J and Fig. 8Y). Taken together, these data indicate that the IG-FN
linker region in BOC can promote HH signaling in cooperation with
either FNIII(1) or FNIII(2), but is not required to activate signaling in
the context of the full-length BOC protein.Discussion
CDON and BOC require distinct modes of membrane attachment to
promote HH signaling
In this study we employed a gain-of-function approach in the
developing chicken neural tube to deﬁne the structural require-
ments for CDON and BOC in the promotion of HH signaling
(summarized in Fig. 9). Previous reports suggested that CDON and
BOC require cell surface attachment to mediate HH signal trans-
duction (Tenzen et al., 2006). Our data conﬁrm and extend these
results to demonstrate that CDON and BOC can promote HH sig-
naling when anchored via an integral (CD4) transmembrane
domain. Surprisingly, we ﬁnd that CDON, but not BOC, can induce
ectopic HH signaling when anchored via a peripheral (GPI)
membrane anchor. These data are the ﬁrst to suggest that, despite
their functional redundancy and structural similarities, these
proteins utilize distinct motifs to mediate HH signal transduction.
The inability of BOC to promote HH pathway activity when
tethered via a peripheral membrane anchor reveals an important
aspect of BOC function, namely that the subcellular localization of
BOC may be especially critical to its activity as a HH co-receptor.
Given that GPI-anchored proteins are frequently targeted to the
apical surface of polarized epithelial cells (Chan et al., 2011;
Megason and McMahon, 2002), these results suggest that during
HH-dependent neural patterning BOC requires targeting to a par-
ticular membrane domain to promote HH signaling. In support of
this idea, recent studies in the limb indicate that CDON and BOC
localize to speciﬁc domains within ﬁlopodial extensions (Kim
et al., 2011). Further, in Drosophila, the CDON and BOC homolog
Ihog controls the cell surface localization of Ptc (Zheng et al.,
2010). While the ability of CDON and BOC to regulate the sub-
cellular distribution of PTCH1 has not been examined, it is possible
that these proteins regulate HH signaling through modulation of
PTCH1 distribution at the cell surface. It is tempting to speculate
that CDON and BOC may regulate the ciliary localization of PTCH1
(Rohatgi et al., 2007), although our data indicate that deletion of a
putative ciliary localization sequence (Corbit et al., 2005) in these
proteins does not affect the function of either CDON or BOC.
One caveat associated with these experiments is that endo-
genous CDON and BOC could complicate our interpretation of the
results. At the time of electroporation (Hamburger–Hamilton stage
11–13) and subsequently at the time of neural patterning analysis
(stage 21–22), Cdon expression is restricted to the ﬂoor plate and
dorsal neural tube, while Boc expression extends further ventrally,
but is still largely excluded from the cells analyzed in these
experiments (Allen et al., 2011; Tenzen et al., 2006). However, we
cannot formally exclude the possibility that endogenous CDON
and BOC impact the activity of the Cdon and Boc expression con-
structs used in this study.
CDON and BOC employ distinct extracellular determinants to promote
HH signaling
In addition to distinct membrane tethering requirements for
CDON and BOC, our data also identify functional differences in the
extracellular domains of these proteins in HH signal transduction.
We ﬁnd that the FNIII domains of CDON are necessary and sufﬁ-
cient to promote HH signaling. This corroborates previous studies
demonstrating physical interactions between the FNIII(3) domain
of CDON with HH ligands (Kang et al., 1997; Tenzen et al., 2006)
and between the FNIII(1) and FNIII(2) domains with PTCH1, and
with other co-receptors (Bae et al., 2011; Izzi et al., 2011). Sur-
prisingly, the FNIII domains of BOC are not sufﬁcient to induce HH
signaling; instead BOC requires an additional motif- a 78 amino
acid region that links the IG and FNIII domains of BOC and works
Fig. 9. Summary of the structural requirements for CDON and BOC in HH signal transduction. Schematic summarizing the structural domain requirements for CDON- and
BOC-mediated promotion of HH signaling. Shared features are listed in the center, while CDON- and BOC-speciﬁc features are listed below each protein. While the IG
domains are dispensable, the FNIII domains are essential for both CDON- and BOC-mediated HH signal transduction. In the absence of the Ig domains, BOC requires an
additional linker region N-terminal to the FNIII domains, whereas CDON does not require this domain to induce HH signaling. Further, BOC requires integral membrane
tethering, whereas CDON effectively drives HH signaling when tethered via either integral or peripheral membrane anchors. BOC also possesses an extracellular proteolytic
cleavage site that may regulate its promotion of HH signaling. Notably, the cytoplasmic domains of both CDON and BOC are dispensable for the promotion of HH signaling
during neural tube patterning.
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HH signaling. BOC also requires an additional juxtamembrane
sequence, which contains a putative matrix metallopeptidase
9 recognition site, to drive ectopic HH signal transduction. While
this domain mediates the release of the BOC extracellular domain
from the cell surface, it remains unknown which protease med-
iates this release. Further, it is unclear whether this cleavage is
actually required to promote BOC-mediated HH signal transduc-
tion. Given that the expression of a secreted BOC protein is not
sufﬁcient to induce HH signaling, one prediction is that proteolytic
cleavage of BOC is not required to promote HH pathway activity.
However, further studies that more precisely delete this cleavage
site will be needed to test this hypothesis.
It is interesting to note that the FNIII(1) and FNIII(2) domains of
both BOC and CDON appear to function redundantly in HH signaling,
but they are not interchangeable. That is, either the FNIII(1) or FNIII
(2) domains of CDON can cooperate with the FNIII(3) domain to
promote HH signaling, as can the analogous domains of BOC as long
as BOC contains the additional linker motif. Surprisingly, the ability
the FNIII domains to promote HH signaling appear to be indepen-
dent of interactions with PTCH1. In particular, BOCFNIII(1-3), which
does interact with PTCH1, does not promote HH signaling; con-
versely CDONFNIII(1,2)/BOCFNIII(3), which does not associate with
PTCH1, does induce HH pathway activity. Future studies are required
to more precisely deﬁne the requirements within the FNIII domains
of CDON and within the linker domain of BOC in order to dissect
their distinct functions in HH pathway activity.While CDON and BOC appear to function redundantly with
GAS1 during HH-dependent neural patterning (Allen et al., 2011)
and craniofacial development (Pineda-Alvarez et al., 2012; Seppala
et al., 2007; Zhang et al., 2011), our data indicate that these pro-
teins employ distinct mechanisms to activate HH signaling. This
suggests that CDON and BOC may exert distinct effects on HH
signaling in different contexts. In support of this notion, genetic
studies indicate that Boc, but not Cdon, controls HH-dependent
digit speciﬁcation (Allen et al., 2011, 2007). Similarly, BOC, but not
CDON is required for SHH-dependent axon guidance in mice
(Fabre et al., 2010; Okada et al., 2006). Conversely, CDON, but not
BOC, is proposed to act as a dependence receptor that activates
apoptosis in the absence of HH ligand (Kang et al., 2002). Our data
provide mechanistic evidence in support of distinct roles for these
proteins in different HH-dependent developmental processes and
correlate with initial studies of these molecules that suggested
distinct functions of the extracellular domains of CDON and BOC in
myogenesis (Kang et al., 2002).
Modeling cell surface interactions of CDON and BOC during HH signal
transduction
CDON and BOC are essential cell surface modulators of the HH
pathway (Kang et al., 1997; Schneider et al., 2012; Tenzen et al.,
2006). However, there are a host of cell surface-associated proteins
that control HH signaling, ranging from the core pathway com-
ponents SMO and PTCH1 to the co-receptor GAS1 (Allen et al.,
2011), and LRP2, which promotes HH signaling during forebrain
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pathway include PTCH1, PTCH2, and HHIP1 (Holtz et al., 2013),
while glypicans act to both promote and inhibit HH signaling in
different contexts (Capurro et al., 2008; Filmus and Capurro, 2014;
Williams et al., 2010).
Given that CDON and BOC interact not only with all HH ligands
(Kavran et al., 2010), but also with each other and with multiple
cell surface HH pathway components, the nature of these inter-
actions, and the context in which these interactions occur (i.e.
from the tissue-level to the sub-cellular distribution of these
proteins) is likely to be a critical determinant in their function in
HH signal transduction. Additionally, it is likely that these inter-
actions and therefore the structural requirements for CDON and
BOC function in HH signal transduction will change in a tissue-
and stage-speciﬁc manner. Therefore, it will be essential to pre-
cisely map these sites of interaction to better understand the
nature of these associations and how perturbation of these inter-
actions affects HH-dependent embryonic development. Notably,
impairment of these interactions has been implicated in devel-
opmental diseases such as holoprosencephaly (Bae et al., 2011).
Disruption of these interactions may also mediate abnormal HH
signaling in the context of cancer; HH-responsive Boc expression
has been demonstrated in medulloblastoma (Lee et al., 2010)
while a potential tumor suppressor role for CDON has also been
proposed (Kang et al., 2002). Thus, the development of tools and
reagents that allow for the precise targeting of speciﬁc domains of
CDON and BOC may provide a means to selectively alter HH sig-
naling in different tissues and in different HH-driven pathologies.Materials and methods
Cdon and Boc constructs
The generation of various Cdon and Boc constructs was performed
using standard molecular biology methods (Sambrook et al., 1989).
Cdon and Boc deletion constructs were created via a modiﬁed PCR-
based mutagenesis protocol (Geiser et al., 2001) using primers
designed to ﬂank the region desired for deletion. All constructs were
cloned into the pCIG vector, which contains the CMV enhancer,
chicken beta-actin promoter, and an internal ribosome entry site
(IRES) followed by nuclearly localized enhanced green ﬂuorescent
protein (3XNLS-EGFP) (Megason and McMahon, 2002). Detailed
information for each construct, including the number of embryos
analyzed for each construct is presented in Fig. S6.
Chicken in ovo electroporations
Chicken in ovo neural tube electroporations were performed as
previously described (Tenzen et al., 2006). DNA constructs were
injected into Hamburger–Hamilton (HH) stage 12–13 chicken
embryos at a concentration of 1 μg/μl in sterile PBS with 1% Fast
Green (VWR). Embryos were visualized by staining with 1% Neutral
Red (Sigma Aldrich) diluted in PBS. 48 h post electroporation,
embryos were dissected and ﬁxed in 4% paraformaldehyde (EMS) for
1 h on ice, and equilibrated overnight in 30% sucrose prior to
embedding in OCT (Tissue-tek). Fertilized eggs were obtained from
the Michigan State University Poultry Farm.
Neural patterning analysis
Immunoﬂuorescent analyses were performed as previously
described (Jeong and McMahon, 2005). Sucrose-equilibrated embryos
were frozen in OCT compound (Tissue-tek) and cryo-sectioned at a
thickness of 12–14 μm at the forelimb level for further neural pat-
terning analysis. The primary antibodies used include 1:20 mouseanti-NKX2.2 (DSHB; 74.5A5), 1:20 mouse anti-NKX6.1 (DSHB;
F55A10), and 1:1000 rabbit anti-OLIG2 (Millipore; AB9610). Anti-
bodies were diluted in blocking buffer containing 3% bovine serum
albumin (Sigma Aldrich), 1% heat inactivated sheep serum, 0.1% Triton
X-100, and 0.02% sodium azide. Alexa 555-conjugated secondary anti-
mouse and anti-rabbit antibodies (Invitrogen) were used at 1:500
dilutions. Nuclei were visualized with DAPI (Invitrogen) diluted
1:30,000 in blocking buffer. Sections were incubated in primary
antibody overnight at 4 °C and in secondary antibody for 1 h at room
temperature. All images were collected on a Leica SP5X confocal
microscope. For each construct a minimum of 6 different embryos
(three sections per embryo) were analyzed. A summary of the
number of embryos analyzed per construct is available in Fig. S6.
Immunoprecipitation and western blot analysis
COS-7 cells were transfected with the speciﬁed DNA constructs
using Lipofectamine 2000 (Life Technologies). Supernatants were
collected through aspiration, and lysates were collected in RIPA
buffer with proteinase inhibitor 48 h post transfection. Lysates were
sonicated and protein concentration was assessed by BCA assay
(Pierce). 50 μg of cell lysate and 30 μl of supernatant were subjected
to SDS-PAGE on a 7.5% polyacrylamide gel. The transferred mem-
branes were blotted with the following primary antibodies: mouse
anti-HA (Covance, 1:1000) or rabbit anti-HA (Bethyl, 1:10,000), rabbit
anti-MYC (Bethyl, 1:1000), goat anti-CDON (R&D systems, AF2429,
1:1000), goat anti-BOC (R&D systems, AF2385, 1:1000), and mouse
anti-Beta-Tubulin (a gift from Dr. Kristen Verhey, 1:1000). All anti-
bodies were diluted in blocking buffer containing TBST, 0.02%
sodium azide and 3% bovine serum albumin (Sigma Aldrich). Fol-
lowing primary antibody incubation, the blots were subjected to
peroxidase-conjugated secondary antibody incubation, with either
HRP-conjugated anti-mouse, anti-rabbit, or anti-goat antibodies
(Jackson ImmunoResearch) all diluted 1:10,000 in blocking buffer.
The blots were incubated for 1 h at room temperature for both pri-
mary and secondary antibodies. After secondary antibody incuba-
tion, the blots were subjected to a 5-minute-incubation in HRP
substrate (Millipore) and developed onto x-ray ﬁlm. Immunopreci-
pitation experiments were performed as previously described (Holtz
et al., 2013; Okada et al., 2006). Quantitation of western blots was
performed using ImageJ (Schneider et al., 2012). Band intensity was
measured, background corrected, and normalized to Beta-Tubulin
intensity (also background corrected) for each individual lane. Rela-
tive expression levels were compared to full-length CDON (Figs. 1
and 4), BOC (Figs. 2 and 5), or BOCFNIII(1-3) (Figs. 6 and 8), all of which
were set to 1.
Phosphatidylinositol-speciﬁc phospholipase C (PI-PLC) treatment
COS-7 cells were transfected in 6-well plates with the speciﬁed
DNA constructs using Lipofectamine 2000 (Life Technologies). 48 h
post transfection cells were treated with 2.5 μl of PI-PLC (Life
Technologies) diluted in 250 μl of serum-free cell media for
30 min at 37 °C. Following PI-PLC treatment, the supernatants and
cell lysates were collected for subsequent western blot analysis.Author contributions
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